University Hospital Henri Mondor, Creteil (France)
Pr Damy’s field of interest are Heart failure and amyloidosis, through to their diagnosis and treatment. His particular current interests include early cardiac diagnostic markers, from biology to imaging. He is a co-author of 150 articles(>60 on amyloidosis). Professor Damy created the “Mondor Amyloidosis Network”, which involves all the clinical facilities for the diagnosis and and treatment of amyloidosis, in addition to a clinical research team. It rapidly became an important multidisciplinary network involving more than 40 healthcare professional. Since 2010, more than 2,800 patients have been referred to the centre for suspicion of cardiac amyloidosis . Professor Damy and his team created a wide educational programme to improve the knowledge and quality of life of the patients: Amylo Patient Education Program (Amylo-PEP). In 2017, the Mondor Amyloidosis Network was appointed Referral Center for Cardiac Amyloidosis in the Cardiogen FrenNetwork.